| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-09 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.22 | 6e-09 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-09 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-08 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.29 | 2e-08 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-07 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-07 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-07 |